Clinical Trials on Complement 3 Glomerulonephritis
Total 1334 results
-
Apellis Pharmaceuticals, Inc.Active, not recruitingC3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Dense Deposit Disease | DDD | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative...United States, Spain, France, Germany, United Kingdom, Netherlands, Brazil, Israel, Japan, Australia, Austria, Italy, Switzerland, Korea, Republic of, Czechia, Belgium, Argentina, Canada, Poland
-
Apellis Pharmaceuticals, Inc.Active, not recruitingC3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Dense Deposit Disease | DDD | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative...United States, Australia, Brazil, Czechia, France, Italy, Korea, Republic of, Netherlands, Spain, Switzerland, United Kingdom
-
Apellis Pharmaceuticals, Inc.AvailableC3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Dense Deposit Disease | DDD | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative...United States
-
Apellis Pharmaceuticals, Inc.Active, not recruitingRenal Transplant | C3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative... and other conditionsUnited States, Australia, Austria, United Kingdom, Brazil, Argentina, France, Italy, Netherlands, Spain, Switzerland
-
BioCryst PharmaceuticalsTerminatedImmunoglobulin A Nephropathy | Membranous Nephropathy | Complement 3 GlomerulopathyFrance, Italy, Spain, United Kingdom
-
Region SkaneRecruitingC3 Glomerulopathy | C3 Glomerulonephritis | Dense Deposit Disease | Membranoproliferative Glomerulonephritis | Complement AbnormalitySweden
-
Q32 Bio Inc.Not yet recruitingIgA Nephropathy | Lupus Nephritis (LN) | C3 (Complement Component 3) Glomerulopathy
-
CSL BehringRecruiting
-
Celldex TherapeuticsTerminatedC3 Glomerulonephritis | Dense Deposit Disease | Membranoproliferative Glomerulonephritis Type IIUnited States
-
Alexion PharmaceuticalsAchillion, a wholly owned subsidiary of AlexionCompletedC3 Glomerulopathy | C3 Glomerulonephritis | Dense Deposit Disease | Immune Complex Mediated Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis Types I, II, and IIINetherlands, Australia, Belgium
-
University Magna GraeciaCompletedIGA GlomerulonephritisItaly
-
Mario Negri Institute for Pharmacological ResearchAlexion PharmaceuticalsCompletedIC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Dense Deposit Disease | Immune Complex Membranoproliferative GlomerulonephritisItaly
-
Nagoya UniversityRohto Pharmaceutical Co., Ltd.Completed
-
Mayo ClinicCompletedGlomerulonephritis, MembranoproliferativeUnited States
-
Gynuity Health ProjectsHopital La RabtaCompleted
-
Columbia UniversityAlexion PharmaceuticalsCompletedDense Deposit Disease | Membranoproliferative GlomerulonephritisUnited States
-
Centre Hospitalier Universitaire de Saint EtienneCompletedIGA GlomerulonephritisFrance
-
Assiut UniversityUnknownMembranoproliferative Glomerulonephritis
-
Apellis Pharmaceuticals, Inc.Active, not recruitingLupus Nephritis | IgA Nephropathy | Membranous Nephropathy | C3 Glomerulonephritis | Dense Deposit DiseaseUnited States
-
Institut Pasteur de LilleCompletedWeight Management | Food ComplementFrance
-
Alexion PharmaceuticalsCompletedC3 Glomerulopathy | C3 Glomerulonephritis | Dense Deposit DiseaseUnited Kingdom, United States
-
The George InstitutePeking University First HospitalCompletedIgA GlomerulonephritisCanada, China, Australia, Malaysia, Hong Kong, India
-
Fernando FervenzaCompleted
-
Mario Negri Institute for Pharmacological ResearchAlexion Pharma Italy s.r.l.Completed
-
Moscow Regional Research and Clinical Institute...TerminatedGlycogen Synthase Kinase 3Russian Federation
-
AlexionTerminatedIC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Dense Deposit Disease | Immune Complex Membranoproliferative GlomerulonephritisUnited States, Australia, Belgium, Italy, Netherlands
-
University of BernITI International Team for Implantology, SwitzerlandRecruiting
-
General Practitioners Research InstituteG3 PharmaceuticalsEnrolling by invitation
-
University of SouthamptonFood Standards Agency, United Kingdom; Ocean NutritionCompletedPlasma Omega-3 StatusUnited Kingdom
-
National Taiwan University HospitalCompletedPrimary GlomerulonephritisTaiwan
-
Asklepios Neurological Clinic Bad SalzhausenAsklepios Schlossberg Clinic Bad KoenigRecruiting
-
Josip Juraj Strossmayer University of OsijekUnknownOmega-3 Polyunsaturated Fatty AcidsCroatia
-
Philips Electronics Nederland B.V. acting through...Completed
-
National Institute of Diabetes and Digestive and...Southwest Pediatric Nephrology Study GroupCompleted
-
National Center for Research Resources (NCRR)Stanford UniversityCompletedIGA Glomerulonephritis
-
Sheba Medical CenterWithdrawnOmega 3 Supplements During PregnancyIsrael
-
Yale UniversityWithdrawnPatients With "ASA 3" DesignationUnited States
-
Catalyst BiosciencesTerminatedPrevious Diagnosis With a Complement-mediated Disease and/or With Clinical Manifestations Reasonably Associated With Complement Factor I DeficiencyUnited States
-
University of JenaCompletedInter-conversion n-3 PUFA, Vegetarians
-
Guangzhou Institute of Respiratory DiseaseThe Fifth Affiliated Hospital of Zunyi Medical CollegeCompletedCOPD | Metabolomics | Omega 3 | Omega 6
-
Qualitas HealthArizona State UniversityCompletedTriglycerides | Cholesterol | Eicosapentaenoic Acid | Omega-3United States
-
Heeger, Peter, M.D.Icahn School of Medicine at Mount Sinai; Alexion PharmaceuticalsTerminatedKidney Transplantation | Delayed Graft Function | Complement ActivityUnited States
-
Mayo ClinicGenentech, Inc.CompletedFibrillary GlomerulonephritisUnited States
-
USDA Grand Forks Human Nutrition Research CenterUnited States Department of Agriculture (USDA); University of North DakotaCompletedOmega-3 Fatty Acids | Lipid PeroxidationUnited States
-
Assiut UniversityUnknownPSGN - Post-Streptococcal Glomerulonephritis
-
Ain Shams UniversityCompletedBone Mineral Density Quantitative Trait Locus 3Egypt
-
University Medical Center GroningenFresenius Medical Care North AmericaCompletedAnti-glomerular Basement Membrane GlomerulonephritisNetherlands
-
Peking University First HospitalTerminatedKidney Diseases | Glomerulonephritis, IGA | Acute Renal Insufficiency | Rapidly Progressive GlomerulonephritisChina
-
Universidade Norte do ParanáCompletedBone Mineral Density Quantitative Trait Locus 3Brazil